Acta Scientific Pharmaceutical Sciences (ISSN: 2581-883X)

Guest Editorial Volume 4 Issue 7

Intravenous High-Dose and Supplementation of Vitamin C Can Effectively Prevent and Treat COVID-19?

Attapon Cheepsattayakorn1,2*, Ruangrong Cheepsattayakorn3 and Utoomporn Sittisingh2

110th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
2St. Theresa International College, Nakorn Nayok, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Changklan, Muang, Chiang Mai, Thailand.

Received: May 26, 2020; Published: June 01, 2020

×

Coronaviruses and influenza viruses, the pandemic viruses can cause acute respiratory distress syndrome (ARDS) contributing to lethally acute lung injuries (ALI) and death. Activation of nuclear factor erythroid 2 (nfe2)-related factor 2 (nrf2), a major regulator of antioxidant response element (ARE)-driven cytoprotective protein expression plays an critical role in preventing cells and tissues from oxidative-stress-induced injury. Both viral and bacterial infections can contribute to cytokine storm that results in increased oxidative stress. Vitamin C is beneficial to critical care management due to its important component of the cellular antioxidant system.

×

References

×

Citation

Citation: Attapon Cheepsattayakorn., et al. “Intravenous High-Dose and Supplementation of Vitamin C Can Effectively Prevent and Treat COVID-19?".Acta Scientific Pharmaceutical Sciences 4.7 (2020): 01-02.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor1.197

Indexed In




News and Events


Contact US